ストックスクリーナーアプリを入手
177.54
0.43%
-0.7412
前日終値:
$178.28
開ける：
$178.3
24時間の取引高:
199.82K
Relative Volume:
0.23
時価総額：
$19.85B
収益：
$10.52B
当期純損益:
$999.00M
株価収益率:
21.23
EPS:
8.3628
ネットキャッシュフロー:
$1.22B
1週間 パフォーマンス:
-2.02%
1か月 パフォーマンス:
-6.00%
6か月 パフォーマンス:
-0.55%
1年 パフォーマンス:
+13.82%
1日の値動き範囲:
$177.25
$178.76
1週間の範囲:
$177.17
$184.73
52週間の値動き範囲:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
DGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
177.54 | 19.83B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
564.29 | 210.57B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
216.73 | 153.21B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
630.40 | 50.75B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.92 | 41.35B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
219.71 | 37.15B | 15.70B | 1.24B | 2.01B | 6.9036 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 開始されました | Redburn Atlantic | Buy |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-01-06 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | Jefferies | Buy |
| 2024-10-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 再開されました | Evercore ISI | In-line |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-12-12 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-06-29 | 開始されました | Piper Sandler | Neutral |
| 2023-05-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-01-23 | 開始されました | Evercore ISI | In-line |
| 2022-11-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-04-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-02-23 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-02 | ダウングレード | Jefferies | Buy → Hold |
| 2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-04 | アップグレード | UBS | Neutral → Buy |
| 2021-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | アップグレード | Argus | Hold → Buy |
| 2020-07-29 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-06-09 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-04-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
| 2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-12-19 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | ダウングレード | Goldman | Neutral → Sell |
| 2019-04-02 | アップグレード | Jefferies | Hold → Buy |
| 2019-03-18 | 再開されました | Credit Suisse | Neutral |
| 2019-01-31 | ダウングレード | Argus | Buy → Hold |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Quest Diagnostics Inc (DGX) 最新ニュース
J.P. Morgan Sticks to Their Hold Rating for Quest Diagnostics (DGX) - The Globe and Mail
Forecasting Quest Diagnostics Incorporated price range with options dataJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Can Quest Diagnostics Incorporated stock beat analyst consensus2025 Price Momentum & Low Drawdown Momentum Trade Ideas - newser.com
Quest Diagnostics Incorporated stock outlook for YEARQuarterly Market Review & Long-Term Growth Portfolio Plans - newser.com
Quest Diagnostics Incorporated stock trend forecastEarnings Recap Summary & Daily Entry Point Alerts - newser.com
What Fibonacci levels say about Quest Diagnostics Incorporated reboundPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollar2025 Macro Impact & Daily Stock Momentum Reports - newser.com
How Quest Diagnostics Incorporated stock performs in high volatility marketsPrice Action & AI Driven Stock Movement Reports - newser.com
Is Quest Diagnostics Incorporated stock in correction or buying zoneProfit Target & Advanced Swing Trade Entry Alerts - newser.com
Labcorp lifts annual profit forecast on strong diagnostic test demand - Reuters
How supply chain issues affect Quest Diagnostics Incorporated stockDay Trade & Reliable Breakout Stock Forecasts - newser.com
Is Quest Diagnostics Incorporated stock supported by innovation pipelineMarket Activity Recap & Trade Opportunity Analysis - Fundação Cultural do Pará
Will Quest Diagnostics Incorporated stock return to pre crisis levelsOptions Play & Low Volatility Stock Recommendations - newser.com
Is Quest Diagnostics Incorporated stock cheap compared to fundamentalsJuly 2025 Sentiment & Fast Momentum Entry Tips - newser.com
Can Quest Diagnostics Incorporated stock surprise with earnings upside2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
How currency fluctuations impact Quest Diagnostics Incorporated stockWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
Why Quest Diagnostics Incorporated stock is a strong buy callTrade Ideas & Weekly Hot Stock Watchlists - newser.com
Weekly Recap: Can Quest Diagnostics Incorporated stock rebound after recent weaknessBuy Signal & Weekly Momentum Stock Picks - Fundação Cultural do Pará
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo! Finance Canada
Quest Diagnostics, Inc. Announces New Study Demonstrates Accuracy of Two Quest AD- Detect®? Tests for Alzheimer's Disease Diagnosis - MarketScreener
Quest Diagnostics (DGX) Advances Alzheimer's Detection with New Blood Tests - GuruFocus
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis - Financial Times
Piper Sandler Adjusts Quest Diagnostics Price Target to $200 From $190, Maintains Neutral Rating - MarketScreener
How to escape a deep drawdown in Quest Diagnostics Incorporated2025 Institutional Moves & Daily Stock Momentum Reports - newser.com
Exit strategy if you’re trapped in Quest Diagnostics IncorporatedPortfolio Growth Summary & Daily Technical Stock Forecast Reports - newser.com
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceShare Buyback & Free Expert Approved Momentum Trade Ideas - newser.com
Strong Earnings Beat and Raised Guidance Could Be a Game Changer for Quest Diagnostics (DGX) - Yahoo Finance
Quest Diagnostics Inc (DGX) 財務データ
収益
当期純利益
現金流量
EPS
0.10%
1.75%
大文字化:
|
ボリューム (24 時間):